Stock listing
927079 Stock Price, News, Filings & Events — Illumina, Inc.
Selected listing: 927079 · LSX · EUR · DE
This page tracks Illumina, Inc.'s 927079:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 927079:LSX. 927079:LSX is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.
- Ticker
- 927079:LSX
- Asset type
- Stock
- Market cap
- $33.13B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LSX
- Currency
- EUR
Illumina, Inc. 927079:LSX stock context
This page tracks Illumina, Inc.'s 927079:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 927079:LSX. 927079:LSX is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.
Latest news from Illumina, Inc.
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
July 30, 2026
Illumina expands Billion Cell Atlas program with new AI drug developers
July 16, 2026
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 9, 2026
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
July 9, 2026
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
June 23, 2026
Research Illumina, Inc.
Illumina, Inc. investor report
Review AI stock analysis and investor report context for 927079:LSX.
Illumina, Inc. company profile
View the public company page for Illumina, Inc. on 6ix.
Illumina, Inc. news
Read company news and market updates connected to Illumina, Inc..
Illumina, Inc. investor events
Find investor webinars, events, and replay context for Illumina, Inc..
Alternate listings
ILMN:NASDAQ
US · USD
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
ILU:GETTEX
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
ILU:TRADEGATE
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
1ILMN:MIL
IT · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
ILMN:BMV
MX · MXN
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
ILU:FWB
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
927079:LS
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
I1LM34:BMFBOVESPA
BR · BRL
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
0J8Z:LSE
GB · USD
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
ILU:SWB
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
4ILMN:EUROTLX
IT · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.
ILU:HAN
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is 927079:LSX.